Steward Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$56K Buy
130
+9
+7% +$4.08K 0.02% 140
2023
Q2
$53K Sell
121
-21
-15% -$9.69K 0.02% 138
2023
Q1
$65K Buy
142
+30
+27% +$14.3K 0.02% 81
2022
Q4
$57K Buy
+112
New +$56.9K 0.03% 73
2022
Q3
Sell
-112
Closed -$54K 458
2022
Q2
$54K Buy
112
+19
+20% +$9.4K 0.04% 83
2022
Q1
$45K Buy
+93
New +$42.5K 0.04% 88

Other funds holding ELV

Steward Financial Group's ELV Position: Q3 2023 in Review

Steward Financial Group increased its Elevance Health (ELV) stake by 7.4% in Q3 2023, buying an estimated $4.08K and bringing the position to 130 shares worth $56K. The position accounts for 0.02% of the portfolio, ranked #140.

Steward Financial Group first reported a position in ELV in Q1 2022 and has held it in 6 quarters since. The position peaked at $65K in Q1 2023. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Steward Financial Group held 130 shares of Elevance Health worth $56K as of Q3 2023.
  • Steward Financial Group bought 9 Elevance Health shares in Q3 2023, an estimated $4.08K.
  • Elevance Health made up 0.02% of Steward Financial Group's portfolio in Q3 2023, its #140 holding.
  • Steward Financial Group first reported a position in Elevance Health in Q1 2022 and has held it in 6 quarters since.
  • Steward Financial Group's Elevance Health position peaked at $65K in Q1 2023.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.